Why is Bliss GVS Pharma falling/rising?

As of 06-Aug, Bliss GVS Pharma Ltd is experiencing a decline in its stock price, currently at Rs 174.50, which reflects a decrease of Rs 4.9 or 2.73%. The stock has underperformed its sector by 0.67% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 2.97% during this period. The stock reached an intraday high of Rs 186.15 but also saw a low of Rs 172.1. Despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, the stock's performance has been negatively impacted by a significant drop in investor participation, with delivery volume falling by 76.71% compared to the 5-day average. There is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Bliss GVS Pharma's short-term performance over the past week shows a decline of 5.19%, which is notably worse than the Sensex's decrease of only 1.15%. However, the stock has performed well over the longer term, with a year-to-date increase of 5.98% compared to the Sensex's 3.08%. This suggests that while the stock is currently facing short-term challenges, it has shown resilience and growth over a longer time frame, indicating potential for recovery if market conditions improve.